InvestorsObserver
×
News Home

Is Avidity Biosciences Inc (RNA) a Good Buy in the Biotechnology Industry?

Tuesday, March 12, 2024 10:43 AM | InvestorsObserver Analysts

Mentioned in this article

Is Avidity Biosciences Inc (RNA) a Good Buy in the Biotechnology Industry?

Avidity Biosciences Inc (RNA) is around the top of the Biotechnology industry according to InvestorsObserver. RNA received an overall rating of 80, which means that it scores higher than 80 percent of all stocks. Avidity Biosciences Inc also achieved a score of 93 in the Biotechnology industry, putting it above 93 percent of Biotechnology stocks. Biotechnology is ranked 18 out of the 148 industries.

Overall Score - 80
RNA has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on RNA!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Avidity Biosciences Inc Stock Today?

Avidity Biosciences Inc (RNA) stock is trading at $21.49 as of 10:40 AM on Tuesday, Mar 12, an increase of $0.47, or 2.24% from the previous closing price of $21.02. The stock has traded between $20.91 and $21.84 so far today. Volume today is below average. So far 101,554 shares have traded compared to average volume of 1,158,991 shares. Click Here to get the full Stock Report for Avidity Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App